Brief: Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an Additional Patent for SLS-007
18/05/2022 13:24
May 18 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS RECEIVES A NOTICE OF ALLOWANCE IN U.S.
FOR
AN ADDITIONAL PATENT FOR SLS-007
* SEELOS THERAPEUTICS INC - PRELIMINARY DATA FROM STUDY IS
EXPECTED IN SECOND HALF OF 2022
Source text for Eikon: ID:nPn470QxSa
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio